Clinigen Group Stock Price, News & Analysis (LON:CLIN)

GBX 1,040 -3.00 (-0.29 %)
(As of 12/14/2017 04:00 PM ET)
Previous CloseGBX 1,040
Today's RangeGBX 1,035 - GBX 1,048
52-Week RangeGBX 700 - GBX 1,187
Volume446,157 shs
Average Volume373,137 shs
Market Capitalization£1.27 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Clinigen Group (LON:CLIN)

Clinigen Group logoClinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies; Idis Managed Access (MA), which is engaged in the consultancy, development, management and implementation of managed access programs for biotechnology and pharmaceutical companies; Idis Global Access (GA), which offers ethical access to post approval and short-supply medicines; Clinigen Specialty Pharmaceuticals (SP), which manufactures and distributes its own and in-licensed specialist, hospital-only medicines around the world, and Link Healthcare, which distributes pharmaceutical products in South Africa, and the Asia and Pacific region.

Receive CLIN News and Ratings via Email

Sign-up to receive the latest news and ratings for CLIN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Bio Therapeutic Drugs
Sub-IndustryN/A
SectorHealthcare
SymbolLON:CLIN
CUSIPN/A
Phone+44-1283-495010

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSGBX 0.03
Net IncomeN/A
Net Margins0.70%
Return on Equity0.98%
Return on Assets0.53%

Miscellaneous

EmployeesN/A
Outstanding Shares122,220,000

Clinigen Group (LON:CLIN) Frequently Asked Questions

What is Clinigen Group's stock symbol?

Clinigen Group trades on the London Stock Exchange (LON) under the ticker symbol "CLIN."

How often does Clinigen Group pay dividends? What is the dividend yield for Clinigen Group?

Clinigen Group announced a dividend on Thursday, September 28th. Stockholders of record on Thursday, November 9th will be paid a dividend of GBX 3.40 per share on Friday, December 1st. This represents a dividend yield of 0.32%. The ex-dividend date of this dividend is Thursday, November 9th. This is an increase from Clinigen Group's previous dividend of $1.60. The official announcement can be accessed at this link. View Clinigen Group's Dividend History.

How were Clinigen Group's earnings last quarter?

Clinigen Group PLC (LON:CLIN) announced its quarterly earnings results on Thursday, September, 28th. The company reported $41.80 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $41.20 by $0.60. The company had revenue of $302.30 million for the quarter. Clinigen Group had a net margin of 0.70% and a return on equity of 0.98%. View Clinigen Group's Earnings History.

Where is Clinigen Group's stock going? Where will Clinigen Group's stock price be in 2017?

6 analysts have issued twelve-month price targets for Clinigen Group's shares. Their predictions range from GBX 970 to GBX 1,360. On average, they expect Clinigen Group's share price to reach GBX 1,200.83 in the next year. View Analyst Ratings for Clinigen Group.

Who are some of Clinigen Group's key competitors?

Who are Clinigen Group's key executives?

Clinigen Group's management team includes the folowing people:

  • Shaun Edward Chilton, Chief Executive Officer, Director (Age 46)
  • Martin James Abell, Chief Financial Officer - Elect, Director (Age 41)
  • A. Miller, Company Secretary
  • Peter Vance Allen, Independent Non-Executive Chairman of the Board (Age 58)
  • John Bacon, Non-Executive Director
  • Peter Lutz George, Non-Executive Director
  • John Hartup, Independent Non-Executive Director
  • Ian J. Nicholson, Independent Non-Executive Director (Age 54)

How do I buy Clinigen Group stock?

Shares of Clinigen Group and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Clinigen Group's stock price today?

One share of Clinigen Group stock can currently be purchased for approximately GBX 1,040.

How big of a company is Clinigen Group?

Clinigen Group has a market capitalization of £1.27 billion.

How can I contact Clinigen Group?

Clinigen Group's mailing address is Pitcairn House Crown Square, First Avenue, STAFFORDSHIRE, DE14 2WW, United Kingdom. The company can be reached via phone at +44-1283-495010.


MarketBeat Community Rating for Clinigen Group (CLIN)

Community Ranking:  4.1 out of 5 (star star star star)
Outperform Votes:  268 (Vote Outperform)
Underperform Votes:  62 (Vote Underperform)
Total Votes:  330
MarketBeat's community ratings are surveys of what our community members think about Clinigen Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Clinigen Group (LON:CLIN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.672.503.00
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 1,200.83GBX 1,145.83GBX 1,041.25GBX 916.20

Clinigen Group (LON:CLIN) Consensus Price Target History

Price Target History for Clinigen Group (LON:CLIN)

Clinigen Group (LON:CLIN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
11/29/2017N+1 SingerReiterated RatingBuyGBX 1,225View Rating Details
11/7/2017Royal Bank of CanadaReiterated RatingOutperformGBX 1,360View Rating Details
11/1/2017Berenberg BankInitiated CoverageHoldGBX 1,200View Rating Details
10/31/2017Peel HuntReiterated RatingBuyGBX 1,350View Rating Details
7/18/2017Numis SecuritiesDowngradeAddGBX 1,100View Rating Details
5/22/2017Stifel NicolausReiterated RatingBuyGBX 970View Rating Details
(Data available from 12/14/2015 forward)

Earnings

Clinigen Group (LON:CLIN) Earnings History and Estimates Chart

Earnings by Quarter for Clinigen Group (LON:CLIN)

Clinigen Group (LON CLIN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/28/2017Y 2017GBX 41.20GBX 41.80£302.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Clinigen Group (LON:CLIN) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Clinigen Group (LON:CLIN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/28/2017GBX 3.400.32%11/9/201711/9/201712/1/2017
3/15/2017GBX 1.600.2%3/23/20173/23/20174/13/2017
9/28/2016GBX 2.700.38%11/3/201611/3/201611/25/2016
3/2/2016GBX 1.300.2%3/17/20163/17/20164/8/2016
9/22/2015GBX 2.300.32%10/15/201510/15/201511/6/2015
9/24/2014GBX 2.100.46%10/16/201410/16/201411/7/2014
2/26/2014GBX 10.19%3/5/20143/5/20143/28/2014
(Data available from 1/1/2013 forward)

Insider Trades

Clinigen Group (LON CLIN) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Clinigen Group (LON:CLIN)

Clinigen Group (LON CLIN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/23/2017Chris RiggInsiderSell4,955GBX 1,017£50,392.35
10/13/2017Shaun Edward ChiltonInsiderSell100,000GBX 1,150£1,150,000
10/2/2017John BaconInsiderSell250,000GBX 1,093£2,732,500
6/28/2017John BaconInsiderSell200,000GBX 843£1,686,000
6/22/2017Peter Georgeformer CEOSell500,000GBX 875£4,375,000
11/11/2016John BaconInsiderSell200,000GBX 717£1,434,000
10/18/2016Shaun Edward ChiltonInsiderSell97,246GBX 750£729,345
5/16/2016Abell,MartinInsiderBuy11,296GBX 518£58,513.28
10/7/2015Edward Chilton,ShaunInsiderSell412,778GBX 685£2,827,529.30
6/3/2015John HartupInsiderSell23,934GBX 644£154,134.96
(Data available from 1/1/2013 forward)

Headlines

Clinigen Group (LON CLIN) News Headlines

Source:
DateHeadline
Did Clinigen Group Plc (AIM:CLIN) Create Value For Investors Over The Past Year?Did Clinigen Group Plc (AIM:CLIN) Create Value For Investors Over The Past Year?
finance.yahoo.com - December 11 at 5:48 PM
Clinigen Group PLC (CLIN) Given Consensus Rating of "Buy" by BrokeragesClinigen Group PLC (CLIN) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - December 2 at 1:50 AM
DIRECTOR DEALINGS: Clinigen Chief Business Officer Sells SharesDIRECTOR DEALINGS: Clinigen Chief Business Officer Sells Shares
www.morningstar.co.uk - November 24 at 11:10 AM
Chris Rigg Sells 4,955 Shares of Clinigen Group PLC (CLIN) StockChris Rigg Sells 4,955 Shares of Clinigen Group PLC (CLIN) Stock
www.americanbankingnews.com - November 24 at 7:46 AM
(artesunate for injection) in South Africa for the Treatment of Patients with Severe Malaria - Business Wire (press release)(artesunate for injection) in South Africa for the Treatment of Patients with Severe Malaria - Business Wire (press release)
www.businesswire.com - November 23 at 4:01 AM
Should Clinigen Group Plc’s (AIM:CLIN) Earnings Decline In Recent Times Worry You?Should Clinigen Group Plc’s (AIM:CLIN) Earnings Decline In Recent Times Worry You?
finance.yahoo.com - November 20 at 6:21 PM
Clinigen Group PLC (CLIN) Given Average Recommendation of "Buy" by BrokeragesClinigen Group PLC (CLIN) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - November 7 at 5:52 AM
Clinigen Group PLC (CLIN) Raises Dividend to GBX 3.40 Per ShareClinigen Group PLC (CLIN) Raises Dividend to GBX 3.40 Per Share
www.americanbankingnews.com - November 4 at 9:32 AM
OBERWEIS ASSET UK Regulatory Announcement: Form 8.3 ... - Business Wire (press release)OBERWEIS ASSET UK Regulatory Announcement: Form 8.3 ... - Business Wire (press release)
www.businesswire.com - October 31 at 11:27 PM
What Should We Expect From Clinigen Group Plc’s (AIM:CLIN) Earnings Over The Next Year?What Should We Expect From Clinigen Group Plc’s (AIM:CLIN) Earnings Over The Next Year?
finance.yahoo.com - October 30 at 4:00 PM
Clinigen Group Plc breached its 50 day moving average in a Bearish Manner : CLIN-GB : October 25, 2017Clinigen Group Plc breached its 50 day moving average in a Bearish Manner : CLIN-GB : October 25, 2017
finance.yahoo.com - October 25 at 5:43 AM
Clinigen Acquires Japan’s Largest Supplier of Unlicensed MedicinesClinigen Acquires Japan’s Largest Supplier of Unlicensed Medicines
finance.yahoo.com - October 23 at 2:40 AM
Hargreave Hale LTD : Form 8.3 - [Clinigen Group plc] - London South East (blog)Hargreave Hale LTD : Form 8.3 - [Clinigen Group plc] - London South East (blog)
www.lse.co.uk - October 19 at 4:43 AM
Clinigen Group Plc :CLIN-GB: Earnings Analysis: 2017 By the Numbers : October 17, 2017Clinigen Group Plc :CLIN-GB: Earnings Analysis: 2017 By the Numbers : October 17, 2017
finance.yahoo.com - October 17 at 11:01 PM
CORRECT(Oct 16): DIRECTOR DEALINGS: Clinigen Group Chief Sells SharesCORRECT(Oct 16): DIRECTOR DEALINGS: Clinigen Group Chief Sells Shares
www.morningstar.co.uk - October 17 at 6:01 PM
DIRECTOR DEALINGS: Clinigen Group Chief Sells Shares To Buy HouseDIRECTOR DEALINGS: Clinigen Group Chief Sells Shares To Buy House
www.morningstar.co.uk - October 16 at 6:03 PM
Shaun Edward Chilton Sells 100,000 Shares of Clinigen Group PLC (CLIN) StockShaun Edward Chilton Sells 100,000 Shares of Clinigen Group PLC (CLIN) Stock
www.americanbankingnews.com - October 16 at 4:32 PM
Form 8.5 (EPT/RI) - Clinigen Group Plc - London South East (blog)Form 8.5 (EPT/RI) - Clinigen Group Plc - London South East (blog)
www.lse.co.uk - October 11 at 11:49 PM
Insider Selling: Clinigen Group PLC (CLIN) Insider Sells 250,000 Shares of StockInsider Selling: Clinigen Group PLC (CLIN) Insider Sells 250,000 Shares of Stock
www.americanbankingnews.com - October 3 at 7:36 AM
Clinigen Group plc: Full Year ResultsClinigen Group plc: Full Year Results
finance.yahoo.com - October 2 at 5:24 PM
Edited Transcript of CLIN.L earnings conference call or presentation 28-Sep-17 8:30am GMTEdited Transcript of CLIN.L earnings conference call or presentation 28-Sep-17 8:30am GMT
finance.yahoo.com - October 2 at 5:24 PM
Should You Be Tempted To Sell Clinigen Group Plc (AIM:CLIN) At Its Current Price?Should You Be Tempted To Sell Clinigen Group Plc (AIM:CLIN) At Its Current Price?
finance.yahoo.com - October 2 at 5:24 PM
Clinigen Group PLCs (CLIN) Add Rating Reiterated at Peel HuntClinigen Group PLC's (CLIN) Add Rating Reiterated at Peel Hunt
www.americanbankingnews.com - September 30 at 6:38 PM
UK Stocks-Factors to watch on Sept 28 - ReutersUK Stocks-Factors to watch on Sept 28 - Reuters
www.reuters.com - September 29 at 8:13 AM
Clinigen Group plc: Full Year Results - Business Wire (press release)Clinigen Group plc: Full Year Results - Business Wire (press release)
www.businesswire.com - September 29 at 8:13 AM
Clinigen Group PLC (CLIN) Announces Quarterly  Earnings ResultsClinigen Group PLC (CLIN) Announces Quarterly Earnings Results
www.americanbankingnews.com - September 28 at 7:42 AM
Cumberland Pharma launches chemo rescue drug Totect in U.S.Cumberland Pharma launches chemo rescue drug Totect in U.S.
seekingalpha.com - September 27 at 7:27 PM
[$$] Clinigen and Quantum Pharma offer lesson to entrepreneurs[$$] Clinigen and Quantum Pharma offer lesson to entrepreneurs
finance.yahoo.com - September 17 at 4:55 PM
Clinigen Agrees GBP150 Million Takeover Of Quantum Pharma (ALLISS)Clinigen Agrees GBP150 Million Takeover Of Quantum Pharma (ALLISS)
www.morningstar.co.uk - September 13 at 6:28 PM
Clinigen Group PLC (CLIN) Receives "Add" Rating from Peel HuntClinigen Group PLC (CLIN) Receives "Add" Rating from Peel Hunt
www.americanbankingnews.com - September 13 at 8:05 AM
Form 8.3 - Clinigen Group plc - AmendmentForm 8.3 - Clinigen Group plc - Amendment
www.businesswire.com - September 8 at 10:39 PM
Form 8.3 - Clinigen Group Plc - London South East (registration) (blog)Form 8.3 - Clinigen Group Plc - London South East (registration) (blog)
www.lse.co.uk - August 29 at 10:43 PM
Octopus Investments Ltd: Form 8.3 - Clinigen Group PlcOctopus Investments Ltd: Form 8.3 - Clinigen Group Plc
www.finanznachrichten.de - August 25 at 7:02 PM
Global Clinical Trial Supplies Market Analysis & Forecasts to 2025 - Market is Expected to Reach USD 3.3 BillionGlobal Clinical Trial Supplies Market Analysis & Forecasts to 2025 - Market is Expected to Reach USD 3.3 Billion
www.prnewswire.com - August 22 at 10:54 PM
Octopus Investments Ltd : Form 8.3 - Clinigen Group plcOctopus Investments Ltd : Form 8.3 - Clinigen Group plc
globenewswire.com - August 22 at 5:52 PM
Rathbones: Form 8.3 - [Clinigen Group PLC]Rathbones: Form 8.3 - [Clinigen Group PLC]
www.finanznachrichten.de - August 21 at 5:05 PM
Peel Hunt Reaffirms Buy Rating for Clinigen Group PLC (CLIN)Peel Hunt Reaffirms Buy Rating for Clinigen Group PLC (CLIN)
www.americanbankingnews.com - August 20 at 7:32 PM
Form 8.3 - Clinigen Group plcForm 8.3 - Clinigen Group plc
www.businesswire.com - August 18 at 5:18 PM
Form 8.3 - AXA INVESTMENT MANAGERS: Clinigen Group PlcForm 8.3 - AXA INVESTMENT MANAGERS: Clinigen Group Plc
www.finanznachrichten.de - August 18 at 5:17 PM
Form 8.5 (EPT/RI) - Clinigen Group Plc - London South East (registration) (blog)Form 8.5 (EPT/RI) - Clinigen Group Plc - London South East (registration) (blog)
www.lse.co.uk - August 17 at 6:33 PM
Form 8 (OPD) - Clinigen Group Plc - London South East (registration) (blog)Form 8 (OPD) - Clinigen Group Plc - London South East (registration) (blog)
www.lse.co.uk - August 17 at 6:33 PM
Form 8.3 - Clinigen Group plc - Business Wire (press release)Form 8.3 - Clinigen Group plc - Business Wire (press release)
www.businesswire.com - August 17 at 6:33 PM
Clinigen Group Gets EU Approval To Push Cardioxane Into New MarketsClinigen Group Gets EU Approval To Push Cardioxane Into New Markets
www.morningstar.co.uk - August 9 at 3:05 AM
Sarepta Therapeutics and Clinigen Launch a Managed Access Program to Treat Patients with Duchenne Muscular ... - GlobeNewswire (press release)Sarepta Therapeutics and Clinigen Launch a Managed Access Program to Treat Patients with Duchenne Muscular ... - GlobeNewswire (press release)
globenewswire.com - July 21 at 11:47 PM
Sarepta Therapeutics and Clinigen Launch a Managed Access Program to Treat Patients with Duchenne Muscular ... - NasdaqSarepta Therapeutics and Clinigen Launch a Managed Access Program to Treat Patients with Duchenne Muscular ... - Nasdaq
www.nasdaq.com - July 20 at 4:28 AM
Sarepta Therapeutics and Clinigen Launch a Managed Access Program to Treat Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 SkippingSarepta Therapeutics and Clinigen Launch a Managed Access Program to Treat Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping
finance.yahoo.com - July 19 at 6:27 PM
Clinigen and Sarepta Therapeutics launch a Managed Access Program to treat patients with Duchenne Muscular Dystrophy amenable to exon 51 skippingClinigen and Sarepta Therapeutics launch a Managed Access Program to treat patients with Duchenne Muscular Dystrophy amenable to exon 51 skipping
finance.yahoo.com - July 19 at 6:27 PM
Clinigen Group Reports "Excellent" Annual Performance In All UnitsClinigen Group Reports "Excellent" Annual Performance In All Units
www.morningstar.co.uk - July 18 at 6:46 PM
Clinigen Group plc: Year End Trading UpdateClinigen Group plc: Year End Trading Update
finance.yahoo.com - July 18 at 3:44 AM
Clinigen Group Plc: Leads amongst peers with strong fundamentalsClinigen Group Plc: Leads amongst peers with strong fundamentals
finance.yahoo.com - July 10 at 5:15 PM

SEC Filings

Clinigen Group (LON:CLIN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Clinigen Group (LON CLIN) Stock Chart for Thursday, December, 14, 2017

Loading chart…

This page was last updated on 12/14/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.